About this item:

213 Views | 82 Downloads

Author Notes:

Jack L. Arbiser, Department of Dermatology, Winship Cancer Institute, Atlanta and Atlanta Veterans Administration Hospital, Emory University School of Medicine, WMB 5309, 1639 Pierce Drive, Atlanta, Georgia 30322, USA. jarbise@emory.edu.

The author states no conflict of interest.

Subjects:

Research Funding:

JLA was supported by the grant RO1 AR47901 and P30 AR42687 Emory Skin Disease Research Core Center Grant from the National Institutes of Health; a Veterans Administration Hospital Merit Award; as well as funds from the Margolis Foundation; Rabinowitch-Davis Foundation for Melanoma Research; and the Betty Minsk Foundation for Melanoma Research.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Dermatology
  • MELANOMA
  • EXPRESSION

PHIPing Out: A Genetic Basis for Tumor Ulceration

Tools:

Journal Title:

Journal of Investigative Dermatology Symposium Proceedings

Volume:

Volume 134, Number 3

Publisher:

, Pages 600-602

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Ulceration is a common negative prognostic marker of solid tumors including melanoma. The signaling basis of ulceration is being elucidated. PHIP has been found to be amplified in wild-type melanomas, resulting in Akt activation and aerobic glycolysis (Warburg effect), associated with ulceration. The ulceration phenotype likely represents the genotype of the reactive oxygen driven tumor, in which reactive oxygen drives angiopoietin-2 production, tumor growth, and invasion. This phenotype is amenable to pharmacologic intervention.

Copyright information:

© 2014 The Society for Investigative Dermatology.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote